OxyContin-maker Purdue Pharma can settle claims against it by paying up to $7.4 billion to end cases filed amid the nation's opioid epidemic.

The deal could end a years-long legal battle over the OxyContin maker's role in the US opioid crisis.

Deal would also require multibillionaire family to give up ownership of the Connecticut-based firm